Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.
Acute non-A, non-B hepatitis developed in twelve patients with primary hypogammaglobulinaemia during treatment with intravenous gammaglobulin prepared by Cohn fractionation of pooled plasma. The illness was clinically and histologically identical to the short-incubation non-A, non-B, hepatitis observed in haemophilic patients receiving factor VIII concentrates. Most of the patients were symptomless, but 10 months after onset ten of the twelve still had abnormal liver function. The occurrence of non-A, non-B hepatitis in agammaglobulinaemics indicates that humoral mechanisms are not essential for production of hepatocyte necrosis in this infection. This outbreak emphasises the need for a screening test to identify the agent in blood products, and shows that Cohn fractionation of plasma does not always inactivate the agent. Furthermore, the finding that the virus can be transmitted in IgG concentrates suggests either that the general population has a very low level of antibodies to the putative virus or that such antibodies are not virus-neutralising.
D000361:Agammaglobulinemia / Q000628:therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D002986:Clinical Trials as Topic; D003208:Concanavalin A / Q000494:pharmacology; D005260:Female; D006526:Hepatitis C / Q000635:transmission*; D006525:Hepatitis, Viral, Human / Q000635:transmission*; D006801:Humans; D007136:Immunoglobulins / Q000009:adverse effects*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D010641:Phenotype; D013601:T-Lymphocytes / Q000187:drug effects
D007136:Immunoglobulins; D003208:Concanavalin A; D001219:Aspartate Aminotransferases